e-learning
resources
Milan 2017
Sunday, 10.09.2017
Infection and exacerbation science
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Peculiarities of Immune Status among Young Patients with Community-Acquired Pneumonia (CAP) during Cytomegaloviral Persistence (CMVP)
K. Chichirello-Konstantinovich (Vinnitsya, Ukraine)
Source:
International Congress 2017 – Infection and exacerbation science
Session:
Infection and exacerbation science
Session type:
Thematic Poster
Number:
987
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Chichirello-Konstantinovich (Vinnitsya, Ukraine). Peculiarities of Immune Status among Young Patients with Community-Acquired Pneumonia (CAP) during Cytomegaloviral Persistence (CMVP). 987
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Risk Factors and Clinical Impact of Fibrotic-Like Changes and the Organizing Pneumonia Pattern in Patients with COVID-19- and Non-COVID-19-induced Acute Respiratory Distress Syndrome.
Source: Virtual Congress 2021 – COVID-19 and acute respiratory failure
Year: 2021
Viral Sepsis in Adults with Community-Acquired Pneumonia
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019
Community-Acquired Pneumococcal Pneumonia in Virologically Suppressed HIV-Infected Adult Patients: A Matched Case-Control Study
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017
Time to Blood Culture Positivity as a Predictor of Clinical Outcomes and Severity in Adults with Bacteremic Pneumococcal Pneumonia
Source: International Congress 2017 – Update on community acquired pneumonia
Year: 2017
Risk Factors for Noninvasive Ventilation Failure in Acute Respiratory Failure with Pneumocystis Jirovecii Pneumonia in Patients without Human Immunodeficiency Virus Infection
Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 1
Year: 2020
Early Fever Associated with Clinical Outcomes in Patients with Coronavirus Disease 2019
Source: Virtual Congress 2021 – COVID - 19: lessons learned
Year: 2021
Acute Respiratory Distress Syndrome in Mechanically-Ventilated Patients with Community-Acquired Pneumonia
Source: International Congress 2018 – Epidemiology and prognostication of critically-ill patients
Year: 2018
O'Donnell Criteria as a Score of Bad Prognosis in Hospitalized Patients with Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis, an Observetional Study
Source: Virtual Congress 2021 – Bronchiectasis
Year: 2021
PES Pathogens in Elderly Patients with Acquired Pneumonia in the Community
Source: Virtual Congress 2020 – Clinical challenges in pneumonia
Year: 2020
Outcome of Nasal High Flow Nasal Oxygen Therapy (HFNO) in Acute Hypoxemic Respiratory Failure (AHRF) on an Acute Respiratory Care Unit (ARCU)
Source: Sleep and Breathing Conference 2021
Year: 2021
Meta-analysis of Acute Coronary Syndrome in Patients with Community-Acquired Pneumonia
Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections
Year: 2020
Non Invasive Ventilation in Acute Respiratory Failure in Patients of Post Tubercular Bronchiectasis: Effectiveness and Predictors of Failure.
Source: International Congress 2017 – TB: co-morbidities and outcome
Year: 2017
Treatment of Adult Lower Respiratory Tract Infections
Source: CME Online 2011
Year: 2011
Late Breaking Abstract - Cytomegalovirus reactivation in COVID-19 patients with Acute Respiratory Distress Syndrome.
Source: Virtual Congress 2021 – Severe acute respiratory failure
Year: 2021
Twenty-year Trend in Mortality among Hospitalized Patients with Pneumococcal Community-Acquired Pneumonia
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018
A Multidisciplinary Multicenter Study Evaluating Risk Factors, Prevalence and Characteristics of Post-COvid-19 Interstitial Lung Syndrome (PCOILS)
Source: Virtual Congress 2021 – Imaging
Year: 2021
Immunogenicity of Mepolizumab in Patients with Severe Eosinophilic Asthma: Experience from the Clinical Development Program
Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD
Year: 2018
SOFA (Sequential Organ Failure Assessment) Score As A Predictor Of Moartality In Ventilated Patients With Multi-drug Resistant Bacteremia
Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 1
Year: 2020
Association of the Estimated Dead Space Fraction and the Ventilatory Ratio with Mortality in Patients with Acute Respiratory Distress Syndrome
Source: International Congress 2019 – Acute respiratory distress syndrome: developments in diagnostics and outcomes
Year: 2019
Risk of Haemophilus Influenzae Infection in Patients with Chronic Obstructive Pulmonary Disease Using Inhaled Corticosteroids: A Cohort Study of 23,789 Outpatients.
Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept